SCHEMBL8679874

SCHEMBL8679874

CC(C(=O)OCl)(c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 1/20 0.52
▸ HDAC4 P56524 1/20 0.52
▸ HDAC1 Q13547 1/20 0.52
▸ HDAC7 Q8WUI4 1/20 0.52
▸ HDAC2 Q92769 1/20 0.52
▸ HDAC10 Q969S8 1/20 0.52
▸ HDAC11 Q96DB2 1/20 0.52
▸ HDAC8 Q9BY41 1/20 0.52
▸ HDAC6 Q9UBN7 1/20 0.52
▸ HDAC9 Q9UKV0 1/20 0.52
▸ HDAC5 Q9UQL6 1/20 0.52
▸ CHRM2 P08172 6/20 0.50
▸ CHRM4 P08173 6/20 0.50
▸ CHRM1 P11229 6/20 0.50
▸ CHRM3 P20309 6/20 0.50
▸ CHRM5 P08912 5/20 0.50
▸ KCNN4 O15554 1/20 0.48
▸ MAPT P10636 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27993791 0.83 MAPT (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL17681401 0.83 HDAC3 (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL27740300 0.82 KCNN4 (0.47) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4022191 0.81 KCNN4 (0.67) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL27972690 0.79 HDAC3 (0.52) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL7057370 0.79 HDAC3 (0.52) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8166205 0.78 ELANE (0.51) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL1986527 0.77 CHRM3 (0.46) CHRM2CHRM4CHRM1CHRM3CHRM5
SCHEMBL7866041 0.77 CYP1A2 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL27264055 0.77 CYP1A2 (0.61) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1287768-C Stable oral suspension formulations PHARMACIA CORP (US) 2006-12-06 — — CN disclosed
CN-1711081-A Proline derivatives having affinity for the alpha-2-delta subunit of calcium channels PFIZER (US) 2005-12-21 — — CN disclosed
CN-1200696-C Patch containing anti-inflammatory agent HISAMITSU PHARMACEUTICAL CO (JP) 2005-05-11 — — CN disclosed
CN-1549704-A Stable oral suspension formulations — 2004-11-24 — — CN disclosed
US-5728911-A CATALYTIC SOLUTION COPOLYMERIZATION OF ETHYLENE WITH POLYUNSATURATED MONOMER DSM COPOLYMER, INC. (US) 1998-03-17 — — US disclosed
EP-0705284-B1 PROCESS FOR THE PREPARATION OF LOW MOLECULAR WEIGHT COPOLYMERS OF ETHYLENE WITH AT LEAST ONE OTHER 1-ALKENE DSM NV (NL) 1997-07-09 — — EP disclosed
EP-0705284-A1 PROCESS FOR THE PREPARATION OF LOW MOLECULAR WEIGHT COPOLYMERS OF ETHYLENE WITH AT LEAST ONE OTHER 1-ALKENE DSM NV (NL) 1996-04-10 — — EP disclosed
WO-1995000564-A1 PROCESS FOR THE PREPARATION OF LOW MOLECULAR WEIGHT COPOLYMERS OF ETHYLENE WITH AT LEAST ONE OTHER 1-ALKENE DSM N.V. (NL) 1995-01-05 — — WO disclosed
EP-0044119-B1 PROCESS FOR THE PREPARATION OF COPOLYMERS OF ETHYLENE WITH AT LEAST ONE OTHER 1-ALKENE STAMICARBON B.V. (NL) 1985-05-29 — — EP disclosed
US-4435552-A COORDINATION CATALYST CONTAINING HALOACYL COMPOUND STAMICARBON B.V. (NL) 1984-03-06 — — US disclosed
EP-0044119-A2 Process for the preparation of copolymers of ethylene with at least one other 1-alkene STAMICARBON B.V. (NL) 1982-01-20 — — EP disclosed
Send feedback